Prior to the pandemic, very few people would have been able to predict how the world would change. The life sciences sector is one that had to adapt quickly to a changing world as research into the COVID-19 virus, treatments, and vaccines were all needed quicker than people were used to working. On top of this need to work at speed to create solutions, several factors made it more difficult. If people had known a pandemic was on the way, they would have done things a bit differently. Here are some examples:
As COVID-19 rages on, most executives are focused on ensuring that the health and safety of each of their employees is the most important aspect of their work. However, there is no denying that Life Science businesses are experiencing ongoing disruptions and are under pressure to support the mission to find new ways to stop the spread. Achieving both of these goals may seem impossible, but many businesses are finding ways to make it work! Take a look at ways to help the Life Science sector continue to function until the pandemic eases.
At the end of 2020, many of us reflected on the huge successes that the Biotech industry had experienced with obtaining IPO funding; we did not expect to see it continue long into 2022. However, it has, and an astonishing number of Biotech firms are enjoying large amounts of funding when they take their company public.
Over the past few years, the world has experienced some devastating blows, from the current pandemic to the loss of people like George Floyd, Ahmaud Arbery, and Daunte Wright. This has left many people keen to address the inequalities people face, moving the country forward into a cohesive and fair place to live. Within the Life Science community, many companies are keen to ensure that their leadership teams and boards are comprised of diverse people, but they struggle to find the right candidates. Find out how a recruitment service like GeneCoda® can help.
When the Omicron variant recently became known, there were fears that it may be as troublesome as the Delta variant – now we know that it has the potential to be even worse; what does it mean for us? Let’s review the effect this new variant may have as it develops over the coming weeks.
The subject of retirement is often discussed by Life Science executives, especially with the ongoing pressure to offer more solutions and support to the global market. The concern that many of us face is the impact of this wave when people have left their positions and how the industry will cope with finding new people to replace them. Let’s take a look at some of the key reasons executives feel the need to leave and learn more about how we can help.
There is no denying the fact that the Life Science industry is in high demand as we all look for improvements in our lives, wanting answers and solutions that can revolutionize our health. With that demand comes a world that is constantly changing and improving, but how can we work out where our focus needs to be and what is better left for the future? We took a look at some of the biggest trends in Life Science right now in a bid to work out where we are headed.